Asperger's syndrome and high-functioning autism

Pediatric Annals

Volumn 38, Issue 1, 2009, Pages 30-35

  Carpenter, Laura Arnstein ^a   Soorya, Latha ^b   Halpern, Danielle ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; MOOD STABILIZER; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ANTISOCIAL BEHAVIOR; ARTICLE; ASPERGER SYNDROME; AUTISM; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CLINICAL FEATURE; COMPULSION; DEVELOPMENTAL DISORDER; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GROUP THERAPY; HUMAN; INTELLIGENCE QUOTIENT; INTERVIEW; LANGUAGE DISABILITY; MOTOR MANNERISM; PARENT; PREVALENCE; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; SCREENING TEST; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOCIAL ADAPTATION; SOCIAL INTERACTION; DIFFERENTIAL DIAGNOSIS; MEDICAL RESEARCH; PATHOPHYSIOLOGY;

ASPERGER SYNDROME; AUTISTIC DISORDER; BIOMEDICAL RESEARCH; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS;

EID: 63049084510     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090101-01     Document Type: Article

References (35)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [text revision]. 4th ed. Washington, DC:American Psychiatric Association; 2000.
2. Ozonoff S, South M, Miller JN. DSM-IV-Defined Asperger Syndrome: Cognitive, Behavioral and Early History Differentiation. Autism. 2000;4(1):29-46.
3. Klin A, Volkmar FR, Sparrow SS, Cicchetti DV, Rourke BP. Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome. J Child Psychol Psychiatry. 1995;36(7):1127-1140.
4. Mayes SD, Calhoun SL, Crites DL.Does DSM-IV Asperger's disorder exist? J Abnorm Child Psychol. 2001;29(3):263-271.
5. Howlin P. Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. J Autism Dev Disord. 2003;33(1):3-13.
6. Fombonne E, Tidmarsh L. Epidemiologic data on Asperger disorder. Child Adolesc Psychiatr Clin N Am. 2003;12(1):15-21, v-vi.
7. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2002. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention. MMWR Surveill Summ. 2007;56(1):12-28.
8. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66(Suppl)10:3-8.
9. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev. 2002;8(3):151-61.
10. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA. 2003;289(1):49-55.
11. Fombonne E. The changing epidemiology of autism. Journal of Applied Research in Intellectual Disabilities. 2005;18(4):281-294.
12. Howlin P, Asgharian A. The diagnosis of autism and Asperger syndrome: findings from a survey of 770 families. Dev Med Child Neurol. 1999;41(12):834-839.
13. Baron-Cohen S, Scott F, Wheelwright S, et al. Can Asperger syndrome be diagnosed at 26 months old? A genetic high-risk single-case study. J Child Neurol. 2006;21(4):351-356.
14. Lord C, Risi S, DiLavore PS, Shulman C, Thurm A, Pickles A. Autism from 2 to 9 years of age. Arch Gen Psychiatry. 2006;63(6):694-701.
15. Chandler S, Charman T, Baird G, et al. Validation of the social communication questionnaire in a population cohort of children with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1324-1332.
16. Campbell JM. Diagnostic assessment of Asperger's disorder: a review of five third-party rating scales. J Autism Dev Disord. 2005;35(1):25-35.
17. Williams J, Scott F, Stott C, Allison C, Bolton P, Baron-Cohen S, Brayne C. The CAST (Childhood Asperger Syndrome Test): test accuracy. Autism. 2005;9(1):45-68.
18. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30(3):205-223.
19. Volkmar FR. Review of Critical Notice: Autism Diagnostic Interview-Revised. J Child Psychol Psychiatry. 2005;46(9):1020-1021.
20. Rao PA, Beidel DC, Murray MJ. Social Skills Interventions for Children with Asperger's Syndrome or High-Functioning Autism: A Review and Recommendations. J Autism Dev Disord. 2008;38(2):353-361.
21. Gevers C, Clifford P, Mager M, Boer F. Brief report: A theory-of-mind-based social-cognition training program for school-aged children with pervasive developmental disorders: an open study of its effectiveness. J Autism Dev Disord. 2006;36(4):567-571.
22. Turner-Brown LM, Perry TD, Dichter GS, Bodfish JW, Penn DL. Brief report: feasibility of social cognition and interaction training for adults with high functioning autism. J Autism Dev Disord. 2008;38(9):1777-1784.
23. Myles BS, Simpson RL, Ormsbee CK, Erickson C. Integrating Preschool Children with Autism with Their Normally Developing Peers: Research Findings and Best Practices Recommendations. Focus Autism Other Dev Disabl. 1993;8(5):1-19.
24. McCracken JT, McGough J, Shah B, et al; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002; 347(5):314-321.
25. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11):1266-1274.
26. Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol. 2005;15(1):116-126.
27. Chugani DC, Muzik O, Behen M, et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol. 1999;45(3):287-295.
28. Hollander E, Phillips A, Chaplin W, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582-589.
29. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53(11):1001-1008.
30. Szatmari P, Bryson SE, Boyle MH, Streiner DL, Duku E. Predictors of outcome among high functioning children with autism and Asperger syndrome. J Child Psychol Psychiatry. 2003;44(4):520-528.
31. Howlin P. The outcome in adult life for people with ASD. In: Volkmar F, ed. Autism and Pervasive Developmental Disorders. 2nd ed. New York, NY: Cambridge University Press; 2007.
32. Howlin P. Outcomes in Autism Spectrum Disorders. In: Volkmar F, Paul R, Klin A, Cohen D, eds. Handbook of Autism and Pervasive Developmental Disorders. Vol 1. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2005:201-220.
33. Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry. 2004;45(2):212-229.
34. Howlin P, Mawhood L, Rutter M.Autism and developmental receptive language disorder - a follow-up comparison in early adult life. II: Social, behavioural, and psychiatric outcomes. J Child Psychol Psychiatry. 2000;41(5):561-578.
35. Anagnostou E, Shevell M. Outcomes of Children with Autism. In: Tuchman R, Rapin I, eds. Autism: a Neurological Disorder of Early Brain Development. London: MacKeith Press; 2006.